PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LifeMD, Inc. (LFMDP)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS53216B2034
CUSIP53216B203
SectorHealthcare
IndustryPharmaceutical Retailers

Highlights

EPS-$2.26
Revenue (TTM)$152.55M
Gross Profit (TTM)$100.37M
EBITDA (TTM)-$13.31M
Year Range$12.58 - $23.18
Short Ratio0.47

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LifeMD, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in LifeMD, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%NovemberDecember2024FebruaryMarchApril
25.35%
22.61%
LFMDP (LifeMD, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

LifeMD, Inc. had a return of 19.82% year-to-date (YTD) and 71.57% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date19.82%5.84%
1 month-0.88%-2.98%
6 months24.75%22.02%
1 year71.57%24.47%
5 years (annualized)N/A11.44%
10 years (annualized)N/A10.46%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-0.72%7.76%14.50%
2023-1.11%0.59%0.94%4.05%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of LFMDP is 96, placing it in the top 4% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of LFMDP is 9696
LifeMD, Inc.(LFMDP)
The Sharpe Ratio Rank of LFMDP is 9797Sharpe Ratio Rank
The Sortino Ratio Rank of LFMDP is 9595Sortino Ratio Rank
The Omega Ratio Rank of LFMDP is 9696Omega Ratio Rank
The Calmar Ratio Rank of LFMDP is 9595Calmar Ratio Rank
The Martin Ratio Rank of LFMDP is 9898Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for LifeMD, Inc. (LFMDP) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


LFMDP
Sharpe ratio
The chart of Sharpe ratio for LFMDP, currently valued at 2.76, compared to the broader market-2.00-1.000.001.002.003.004.002.76
Sortino ratio
The chart of Sortino ratio for LFMDP, currently valued at 3.71, compared to the broader market-4.00-2.000.002.004.006.003.71
Omega ratio
The chart of Omega ratio for LFMDP, currently valued at 1.56, compared to the broader market0.501.001.501.56
Calmar ratio
The chart of Calmar ratio for LFMDP, currently valued at 2.61, compared to the broader market0.002.004.006.002.61
Martin ratio
The chart of Martin ratio for LFMDP, currently valued at 21.00, compared to the broader market0.0010.0020.0030.0021.00
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.05, compared to the broader market-2.00-1.000.001.002.003.004.002.05
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.98, compared to the broader market-4.00-2.000.002.004.006.002.98
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.002.004.006.001.55
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.05, compared to the broader market0.0010.0020.0030.008.05

Sharpe Ratio

The current LifeMD, Inc. Sharpe ratio is 2.76. A Sharpe ratio higher than 2.0 is considered very good.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2024FebruaryMarchApril
2.76
2.05
LFMDP (LifeMD, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

LifeMD, Inc. granted a 10.15% dividend yield in the last twelve months. The annual payout for that period amounted to $2.22 per share.


PeriodTTM20232022
Dividend$2.22$2.22$2.29

Dividend yield

10.15%11.53%16.33%

Monthly Dividends

The table displays the monthly dividend distributions for LifeMD, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.55$0.00$0.00
2023$0.55$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00
2022$0.62$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-4.92%
-3.92%
LFMDP (LifeMD, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the LifeMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LifeMD, Inc. was 38.92%, occurring on Jun 27, 2022. Recovery took 256 trading sessions.

The current LifeMD, Inc. drawdown is 4.92%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-38.92%Oct 15, 2021175Jun 27, 2022256Jul 5, 2023431
-11.83%Jul 6, 20232Jul 7, 2023122Dec 29, 2023124
-6.52%Apr 9, 20245Apr 15, 2024
-5.55%Jan 3, 20247Jan 11, 202419Feb 8, 202426
-2.44%Mar 5, 20242Mar 6, 20242Mar 8, 20244

Volatility

Volatility Chart

The current LifeMD, Inc. volatility is 10.14%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%NovemberDecember2024FebruaryMarchApril
10.14%
3.60%
LFMDP (LifeMD, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of LifeMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items